Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia

Leukemia. 2010 Apr;24(4):877-81. doi: 10.1038/leu.2009.298. Epub 2010 Jan 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-ribosyl Cyclase 1 / genetics*
  • ADP-ribosyl Cyclase 1 / metabolism
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Genes, Immunoglobulin Heavy Chain / genetics
  • Genetic Variation / physiology*
  • Genotype
  • Humans
  • Immunoglobulin Variable Region / genetics
  • Interferon Regulatory Factors / genetics*
  • Interferon Regulatory Factors / metabolism
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality*
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Survival Rate
  • Treatment Outcome
  • Young Adult
  • ZAP-70 Protein-Tyrosine Kinase / genetics
  • ZAP-70 Protein-Tyrosine Kinase / metabolism

Substances

  • Immunoglobulin Variable Region
  • Interferon Regulatory Factors
  • interferon regulatory factor-4
  • ZAP-70 Protein-Tyrosine Kinase
  • ZAP70 protein, human
  • ADP-ribosyl Cyclase 1